India to Israel: Bortezomib Export Trade Route
India has recorded 13 verified shipments of Bortezomib exported to Israel, representing a combined trade value of $1.1M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $85.9K USD. The leading Indian exporter is MSN LABORATORIES PRIVATE LIMITED, which accounts for 72% of total export value with 11 shipments worth $805.4K USD. On the buying side, MEDISON PHARMA is the largest importer in Israel with $440.7K USD in purchases. The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MSN LABORATORIES PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Israel Bortezomib corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $1.1M USD. The route is dominated by MSN LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's bortezomib manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $85.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with bortezomib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 15.4%, placing it at rank #12 among India's top bortezomib export destinations globally.
On the import side, key buyers of Indian bortezomib in Israel include MEDISON PHARMA, TARO INTERNATIONAL LTD., MEDISON PHARMA7 HATNUFA ST KODAK BUILDING and 4 others. MEDISON PHARMA is the single largest importer with 6 shipments valued at $440.7K USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ1
- Primary modeSea freight
- Top portHYDERABAD ACC (INHYD4)
Market Position
- Global rank#12
- Annual growth+15.4%
- Demand growth+15.2%
- Regulatory ease88/100
Top 10 Indian Bortezomib Exporters to Israel
Showing top 10 of 3 Indian suppliers exporting Bortezomib to Israel, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED Avg $73.2K per shipment | 11 | $805.4K | 72.2% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $246.5K per shipment | 1 | $246.5K | 22.1% |
| 3 | MSN LABORATORIES PRIVATE LIMITED Avg $64.3K per shipment | 1 | $64.3K | 5.8% |
This table shows the top 10 of 3 Indian companies exporting bortezomib to Israel, ranked by total trade value. The listed exporters are: MSN LABORATORIES PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MSN LABORATORIES PRIVATE LIMITED . MSN LABORATORIES PRIVATE LIMITED is the dominant supplier with 11 shipments worth $805.4K USD, giving it a 72% market share.
Top 10 Bortezomib Importers in Israel
Showing top 10 of 7 known buyers in Israel receiving Bortezomib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian bortezomib in Israel include MEDISON PHARMA, TARO INTERNATIONAL LTD., MEDISON PHARMA7 HATNUFA ST KODAK BUILDING, MEDIHOME LTD, MEDOMIE PHARMA, , among 7 total buyers. The largest importer is MEDISON PHARMA, accounting for $440.7K USD across 6 shipments — representing 39% of all bortezomib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDISON PHARMA | 6 | $440.7K | 39.5% |
| 2 | TARO INTERNATIONAL LTD. | 1 | $246.5K | 22.1% |
| 3 | MEDISON PHARMA7 HATNUFA ST KODAK BUILDING | 1 | $124.7K | 11.2% |
| 4 | MEDIHOME LTD | 2 | $120.8K | 10.8% |
| 5 | MEDOMIE PHARMA, | 1 | $64.3K | 5.8% |
| 6 | TO THE ORDER OF | 1 | $63.3K | 5.7% |
| 7 | 'TO THE ORDER | 1 | $56.0K | 5.0% |
Top 10 Bortezomib Formulations Imported by Israel
Showing top 10 of 10 product formulations shipped on the India to Israel Bortezomib route, ranked by trade value
Israel imports a wide range of bortezomib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — BORTEZOMIB TARO INJECTION 3.5MG (BORTEZOMIB 3.5MG POWDER FOR SOLUTION FOR INJECTION) [3934 PACK X 1 VIAL] — accounts for $246.5K USD across 1 shipments. A total of 10 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BORTEZOMIB TARO INJECTION 3.5MG (BORTEZOMIB 3.5MG POWDER FOR SOLUTION FOR INJECTION) [3934 PACK X 1 VIAL] | 1 | $246.5K | 22.1% |
| 2 | BORTEZOMIBE MEDOMIE 3.5MG (1 VIAL) MEDOMIE PHARMA- | 3 | $194.6K | 17.4% |
| 3 | BORTEZOMIB MEDOMIE 3.5MG 1 VIAL MEDOMIE PHARMA | 1 | $124.7K | 11.2% |
| 4 | BORTEZOMIB MEDOMIE 3.5MG (1 VIAL) MEDOMIE PHARMA (6104 PAC) | 1 | $121.8K | 10.9% |
| 5 | Bortezomib Medomie 3.5mg (1 Vial) Medomie Pharma- | 2 | $120.8K | 10.8% |
| 6 | BORTEZOMIB MEDOMIE 3.5MG (1 VIAL) MEDOMI | 1 | $64.3K | 5.8% |
| 7 | MSN PHARMACEUTICAL PRODUCT NAME BORTEZOMIB MEDOMIE 3 5MG 1 VIAL MEDOMIE PHARMA | 1 | $63.3K | 5.7% |
| 8 | BORTEZOMIB MEDOMIE 3.5MG (1 VIAL) MEDOMIE PHARMA (3117 PAC)NOS | 1 | $62.3K | 5.6% |
| 9 | BORTEZOMIB MEDOMIE 3.5MG (1 VIAL) MEDOMIE PHARMA (3091 PAC) | 1 | $61.9K | 5.5% |
| 10 | MSN PHARMACEUTICALS: Bortezomib Medomie | 1 | $56.0K | 5.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 83%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ACC (INHYD4) handles the highest volume with 4 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's bortezomib exports to Israel are driven primarily by a handful of large-scale manufacturers. MSN LABORATORIES PRIVATE LIMITED with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Israel benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MSN LABORATORIES PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MSN LABORATORIES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $85.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as bortezomibe medomie 3.5mg (1 vial) medomie pharma- and bortezomib medomie 3.5mg 1 vial medomie pharma, suggesting that buyers in Israel tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MEDISON PHARMA is the largest importer with 6 shipments worth $440.7K USD — representing 39% of all bortezomib imports from India on this route. A total of 7 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.1M
- Avg. Shipment
- $85.9K
- Suppliers
- 3
- Buyers
- 7
- Transit (Sea)
- ~29 days
- Annual Growth
- +15.4%
Related Analysis
Other Bortezomib Routes
Unlock the Full India to Israel Bortezomib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 13 shipments on this route.
Frequently Asked Questions — India to Israel Bortezomib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Bortezomib to Israel?
The leading Indian exporters of Bortezomib to Israel are MSN LABORATORIES PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, MSN LABORATORIES PRIVATE LIMITED . MSN LABORATORIES PRIVATE LIMITED holds the largest market share at approximately 72% of total trade value on this route.
Q What is the total value of Bortezomib exports from India to Israel?
India exports Bortezomib to Israel worth approximately $1.1M USD across 13 recorded shipments. The average value per shipment is $85.9K USD.
Q Which ports does India use to ship Bortezomib to Israel?
The most active port of origin is HYDERABAD ACC (INHYD4) with 4 shipments. Indian exporters primarily use sea freight for this route, with 83% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Israel for Bortezomib?
The average transit time for Bortezomib shipments from India to Israel is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Israel Bortezomib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.4% with demand growth tracking at 15.2%. The route is ranked #12 among India's top Bortezomib export destinations globally.
Q How many suppliers are active on the India to Israel Bortezomib route?
There are currently 3 active Indian suppliers exporting Bortezomib to Israel. The market is moderately concentrated with MSN LABORATORIES PRIVATE LIMITED accounting for 72% of total shipment value.
Q Who are the main importers of Bortezomib from India in Israel?
The leading importers of Indian Bortezomib in Israel include MEDISON PHARMA, TARO INTERNATIONAL LTD., MEDISON PHARMA7 HATNUFA ST KODAK BUILDING, MEDIHOME LTD, MEDOMIE PHARMA, . MEDISON PHARMA is the largest buyer with 6 shipments worth $440.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Israel export trade corridor identified from Indian Customs (DGFT) records for Bortezomib.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 7 importers in Israel matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 13 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists